Wedbush Remains Bullish on Amazon.com (AMZN) Following 3Q

SunTrust Robinson Humphrey Remains Sidelined on Amazon.com (AMZN); Reiterates $850 Price Target

October 28, 2016 8:43 AM EDT

SunTrust Robinson Humphrey reiterated a Hold rating and $850.00 price target on Amazon.com (NASDAQ: AMZN) following the company's 3Q earnings report. Incremental margins for 3Q were just 2% on a consolidated basis. Retail incremental margins were -2% as North American margins expanded just 20bps and... More

Baird Reiterates Buy on Amazon.com (AMZN) Following 3Q

October 28, 2016 8:37 AM EDT

Baird reiterated an Outperform rating and $850.00 price target on Amazon.com (NASDAQ: AMZN) following the company's 3Q earnings report. AMZN reported revenues of $32.7B, above Baird's expectations and in-line with consensus. 4Q16 revenue guidance of $42B-$45.5B was in-line with consensus of $44.6B,... More

Needham & Company Remains Sidelined on Amazon.com (AMZN) Following Mixed 3Q

October 28, 2016 8:06 AM EDT

Needham & Company reiterated a Hold rating on Amazon.com (NASDAQ: AMZN) following the company's 3Q earnings report. AMZN reported revenue of $32.7B, in-line with consensus. CSOI margin, or non-GAAP operating income margin was 4.2%, increasing y/y from 3.9%, but decreasing q/q from 6.9%, a significant... More

Amazon (AMZN) Bullish View Reiterated at Mizuho Despite Op Margin Pressure

October 28, 2016 7:55 AM EDT

Mizuho Securities analyst Neil Doshi reiterated a Buy rating and $920 price target on Amazon.com (NASDAQ: AMZN)

The analyst commented, "Amazon may have just kissed op margin expansion good bye for the rest of this year and possibly for next year, as... More

Jefferies Reiterates Buy on Amazon.com (AMZN) Following Mixed Quarter

October 28, 2016 7:46 AM EDT

Jefferies reiterated a Buy rating and $950.00 price target on Amazon.com (NASDAQ: AMZN) following the company's 3Q earnings report. Net sales were up 29% Y/Y to $32.71B vs the Street's $32.69B. EPS of $0.52 came in below consensus at $0.77. 4Q guidance was below... More

Wall St. falls as FBI to review more Clinton emails

October 28, 2016 7:28 AM EDT

By Chuck Mikolajczak

NEW YORK (Reuters) - U.S. stocks declined in a volatile session on Friday but were able to partially recover from a sharp drop spurred by news the FBI will review more emails related to Democratic presidential candidate Hillary Clinton's private email use.

Each of the three major indexes on Wall Street fell to session lows, with the S&P 500 dropping 1 percent in an hour, after FBI Director James Comey said in a letter to several congressional Republicans the agency had learned of the existence of emails that appeared to be pertinent to its... More

Amazon (AMZN) PT Raised to $1250 at Susquehanna

October 28, 2016 7:15 AM EDT

Susquehanna analyst Shyam Patil reiterated a Positive rating and raised his price target on Amazon.com (NASDAQ: AMZN) to $1,250.00 (from $950.00), saying 'we've seen this movie before."

Patel highlighted:

Our thoughts going forward and upcoming catalysts. Near-term profitability will be the main topic of discussion given the 3Q CSOI miss and lower than expected 4Q guide. The investment is heavier than normal and is likely to persist (though remain lumpy), but makes... More

Cowen Affirms Amazon (AMZN) at 'Outperform'; Thesis Unchanged Following Q3 Report

October 28, 2016 6:44 AM EDT

Cowen and Company affirms Amazon.com (Nasdaq: AMZN) at Outperform with a price target of $960 following Q3 results release on Thursday night.

Analyst John Blackledge noted that the firm's thesis on Amazon remains unchanged. The analyst commented on Friday: AMZN... More

After-Hours Stock Movers 10/27: (CVRS) (SMCI) (GIMO) (LOGM) (CRUS) (HBI) (VRSN) (CBI) (SGEN) (ACTG) (CY) Higher; (SYMX) (YRCW) (SYNA) (CENX) (MXK) (ATEN) (MLNX) (ASNG) (AMZN) Lower

October 27, 2016 6:11 PM EDT

Today's After-Hours Movers:

Corindus Vascular Robotics (NYSE: CVRS) +38%; announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its CorPath GRX, the second generation of its CorPath Vascular Robotic System. Corindus expects to commence commercialization of CorPath GRX in the first quarter of 2017.

Super Micro Computer (NASDAQ: SMCI) +12.9%; reported Q1 EPS of $0.26, $0.07 better than the analyst estimate of $0.19. Revenue for the quarter came in at $529 million versus the consensus estimate of $503.64 million.

Gigamon, Inc. (NYSE:... More

Amazon.com (AMZN) Misses Q3 EPS by 26c

October 27, 2016 4:02 PM EDT

Amazon.com (NASDAQ: AMZN) reported Q3 EPS of $0.52, $0.26 worse than the analyst estimate of $0.78. Revenue for the quarter came in at $32.7 billion versus the consensus estimate of $32.69 billion.

GUIDANCE:

Amazon.com sees Q4 2016 revenue of $42.0-45.5 million, versus the consensus of... More

Amazon.com (AMZN) Misses Q3 EPS by 26c, Offers Q4 Guidance

October 27, 2016 4:02 PM EDT

Amazon.com (NASDAQ: AMZN) reported Q3 EPS of $0.52, $0.26 worse than the analyst estimate of $0.78. Revenue for the quarter came in at $32.7 billion versus the consensus estimate of $32.69 billion.

GUIDANCE:

Amazon.com sees Q4 2016 revenue of $42-45.5 billion, versus the consensus... More

Amazon (AMZN) October weekly 820 straddle priced for movement of 6% into Q3

October 27, 2016 3:32 PM EDT

Amazon.com (NASDAQ: AMZN) October weekly 820 straddle priced for movement of 6% into Q3

... More

Amazon (AMZN) October weekly call option implied volatility at 109 into Q3

October 27, 2016 8:49 AM EDT

Amazon.com (NASDAQ: AMZN) October weekly call option implied volatility is at 109, November is at 57; compared to its 52-week range of 15 to 53 into the expected release of Q3 results today after the market close.

... More

Stocks dip as earnings pour in, consumer discretionary lags

October 27, 2016 7:34 AM EDT

By Chuck Mikolajczak

NEW YORK (Reuters) - U.S. stocks dipped in a choppy session after the latest round of earnings reports, as a decline in the consumer discretionary sector and interest-rate sensitive stocks outweighed gains in healthcare names.

The S&P 500 healthcare index rose 0.53 percent to help keep the S&P 500 near the unchanged mark, buoyed by strong results and forecasts from Bristol-Myers (NYSE: BMY), up 5.4 percent and Celgene (NASDAQ: CELG), up 6.4 percent. The two drugmakers were the top boosts to the S&P 500.

... More

Trading Radar for 10/27: Alphabet (GOOG), Amazon (AMZN), Twitter (TWTR) Ford (F), Baidu.com (BIDU) Report

October 26, 2016 2:46 PM EDT

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Economics:
8:30am EDT

Initial Claims - Street sees 259kContinuing Claims - no Street consensusDurable Orders - Street sees 0.3%Durable Orders: ex. Transportation - Street sees 0.3%

Earnings:

Acorda Therapeutics (Nasdaq: ACOR) - no Street consensus
Aetna (NYSE: AET) - consensus EPS $2.03
Agenus (Nasdaq: AGEN) - consensus loss $0.29
Air Products (NYSE:... More